These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 23861562)
1. Association of serum myeloid cells of soluble triggering receptor-1 level with myocardial dysfunction in patients with severe sepsis. Tao F; Peng L; Li J; Shao Y; Deng L; Yao H Mediators Inflamm; 2013; 2013():819246. PubMed ID: 23861562 [TBL] [Abstract][Full Text] [Related]
2. High Serum sTREM-1 Correlates With Myocardial Dysfunction and Predicts Prognosis in Septic Patients. Li Z; Zhang E; Hu Y; Liu Y; Chen B Am J Med Sci; 2016 Jun; 351(6):555-62. PubMed ID: 27238916 [TBL] [Abstract][Full Text] [Related]
3. Serum soluble triggering receptor expressed on myeloid cells-1 and procalcitonin can reflect sepsis severity and predict prognosis: a prospective cohort study. Li Z; Wang H; Liu J; Chen B; Li G Mediators Inflamm; 2014; 2014():641039. PubMed ID: 24672147 [TBL] [Abstract][Full Text] [Related]
4. Dynamic changes of serum soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) reflect sepsis severity and can predict prognosis: a prospective study. Zhang J; She D; Feng D; Jia Y; Xie L BMC Infect Dis; 2011 Mar; 11():53. PubMed ID: 21356122 [TBL] [Abstract][Full Text] [Related]
5. [Expression of soluble triggering receptor expressed on myeloid cells-1 in septic patients and its relation with prognosis]. Sun J; Song SD; Zhao HJ Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 May; 23(5):305-8. PubMed ID: 21549071 [TBL] [Abstract][Full Text] [Related]
6. Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock. Ríos-Toro JJ; Márquez-Coello M; García-Álvarez JM; Martín-Aspas A; Rivera-Fernández R; Sáez de Benito A; Girón-González JA PLoS One; 2017; 12(4):e0175254. PubMed ID: 28380034 [TBL] [Abstract][Full Text] [Related]
7. sTREM-1 predicts intensive care unit and 28-day mortality in cancer patients with severe sepsis and septic shock. Ravetti CG; Moura AD; Vieira ÉL; Pedroso ÊR; Teixeira AL J Crit Care; 2015 Apr; 30(2):440.e7-13. PubMed ID: 25541104 [TBL] [Abstract][Full Text] [Related]
8. Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study. Su L; Han B; Liu C; Liang L; Jiang Z; Deng J; Yan P; Jia Y; Feng D; Xie L BMC Infect Dis; 2012 Jul; 12():157. PubMed ID: 22809118 [TBL] [Abstract][Full Text] [Related]
9. Significance of soluble triggering receptor expressed on myeloid cells-1 elevation in patients admitted to the intensive care unit with sepsis. Charles PE; Noel R; Massin F; Guy J; Bollaert PE; Quenot JP; Gibot S BMC Infect Dis; 2016 Oct; 16(1):559. PubMed ID: 27729010 [TBL] [Abstract][Full Text] [Related]
10. Soluble TREM-1 Serum Level can Early Predict Mortality of Patients with Sepsis, Severe Sepsis and Septic Shock. Jedynak M; Siemiatkowski A; Mroczko B; Groblewska M; Milewski R; Szmitkowski M Arch Immunol Ther Exp (Warsz); 2018 Aug; 66(4):299-306. PubMed ID: 29282483 [TBL] [Abstract][Full Text] [Related]
11. [Clinical study on plasma soluble triggering receptor expressed on myeloid cells-1 in patients with sepsis]. Wang HX; Li ZY Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 May; 23(5):283-5. PubMed ID: 21549065 [TBL] [Abstract][Full Text] [Related]
12. Can sTREM-1 predict septic shock & death in late-onset neonatal sepsis? A pilot study. Arízaga-Ballesteros V; Alcorta-García MR; Lázaro-Martínez LC; Amézquita-Gómez JM; Alanís-Cajero JM; Villela L; Castorena-Torres F; Lara-Díaz VJ Int J Infect Dis; 2015 Jan; 30():27-32. PubMed ID: 25461656 [TBL] [Abstract][Full Text] [Related]
13. Dynamic changes in serum soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) and its gene polymorphisms are associated with sepsis prognosis. Su L; Liu C; Li C; Jiang Z; Xiao K; Zhang X; Li M; Yan P; Feng D; Xie L Inflammation; 2012 Dec; 35(6):1833-43. PubMed ID: 22798017 [TBL] [Abstract][Full Text] [Related]
14. Increased levels of soluble triggering receptor expressed on myeloid cells-1 in patients with acute pancreatitis. Yasuda T; Takeyama Y; Ueda T; Shinzeki M; Sawa H; Takahiro N; Kamei K; Ku Y; Kuroda Y; Ohyanagi H Crit Care Med; 2008 Jul; 36(7):2048-53. PubMed ID: 18552693 [TBL] [Abstract][Full Text] [Related]
15. Endocan and Soluble Triggering Receptor Expressed on Myeloid Cells-1 as Novel Markers for Neonatal Sepsis. Saldir M; Tunc T; Cekmez F; Cetinkaya M; Kalayci T; Fidanci K; Babacan O; Erdem G; Kocak N; Sari E; Akgul EO; Kul M Pediatr Neonatol; 2015 Dec; 56(6):415-21. PubMed ID: 26341458 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of urine sTREM-1 for sepsis and relevant acute kidney injuries: a prospective study. Su LX; Feng L; Zhang J; Xiao YJ; Jia YH; Yan P; Feng D; Xie LX Crit Care; 2011; 15(5):R250. PubMed ID: 22023777 [TBL] [Abstract][Full Text] [Related]
17. [Value of urine soluble triggering receptor expressed on myeloid cells-1 in the early diagnosis of sepsis associated acute kidney injury]. Yuan ZK; Fang F; Liu CJ; Li J; Chen YF; Xu F Zhonghua Er Ke Za Zhi; 2018 May; 56(5):342-346. PubMed ID: 29783819 [TBL] [Abstract][Full Text] [Related]
18. Circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as diagnostic and prognostic marker in neonatal sepsis. Adly AA; Ismail EA; Andrawes NG; El-Saadany MA Cytokine; 2014 Feb; 65(2):184-91. PubMed ID: 24290866 [TBL] [Abstract][Full Text] [Related]
19. Differential pattern of cell-surface and soluble TREM-1 between sepsis and SIRS. Oku R; Oda S; Nakada TA; Sadahiro T; Nakamura M; Hirayama Y; Abe R; Tateishi Y; Ito M; Iseki T; Hirasawa H Cytokine; 2013 Jan; 61(1):112-7. PubMed ID: 23046618 [TBL] [Abstract][Full Text] [Related]
20. Early serum levels of soluble triggering receptor expressed on myeloid cells-1 in septic patients: correlation with monocyte gene expression. Dimopoulou I; Pelekanou A; Mavrou I; Savva A; Tzanela M; Kotsaki A; Kardara M; Orfanos SE; Kotanidou A; Giamarellos-Bourboulis EJ J Crit Care; 2012 Jun; 27(3):294-300. PubMed ID: 21855288 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]